Abstract
Objectives To investigate the incidence of occult cancer in patients diagnosed with adenocarcinoma in situ through punch biopsy or endocervical curettage.
Methods We examined the clinicopathological characteristics of patients diagnosed with adenocarcinoma in situ using punch biopsy or endocervical curettage at four institutes in the Republic of Korea from 2003 to 2011. We investigated the incidence of occult cancer in conization or hysterectomy specimens and whether the occult cancer was detected through conization.
Results Twenty patients diagnosed with adenocarcinoma in situ through punch biopsy or endocervical curettage were enrolled. Six out of the 20 patients had occult cervical cancer, and four out of the six patients had cervical cancer at or greater than stage 1A1 with lymphovascular space invasion. Two out of four patients were diagnosed with invasive cervical cancer through conization and underwent radical hysterectomy without adjuvant radiotherapy. The other two patients underwent extrafascial hysterectomy without preoperative conization and received adjuvant radiotherapy.
Conclusion A significant number of patients diagnosed with adenocarcinoma in situ through punch biopsy or endocervical curettage have occult cancer. Conization should be performed to identify occult cancer and optimize the extent of surgery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Seoul National University Bundang Hospital gave ethical approval for this work (B-1203-148-106).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The authors declare no conflicts of interest related to this work.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
